PR Newswire | Jan 27, 2022 05:29PM EST

01/27 16:28 CST

Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference NEW BRUNSWICK, N.J., Jan. 27, 2022

NEW BRUNSWICK, N.J., Jan. 27, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-citis-2022-virtual-healthcare-conference-301470256.html

SOURCE Johnson & Johnson